Immunotherapy Trial Started in Patients with Inoperable Pancreatic Cancer – PR Web (press release)
|
Immunotherapy Trial Started in Patients with Inoperable Pancreatic Cancer
PR Web (press release) Based on preliminary evidence the immunotherapy-induced decrease of this surrogate marker is correlated with tumor shrinkage and prolonged survival. Pancreatic cancer is the deadliest form of cancer. It is estimated that in 2017, 53,670 Americans will … |
